CDTI Innovación invests in ARTHEx Biotech, alongside Invivo Ventures and Columbus

by CDTI Innovación

ARTHEx Biotech is a Valencian clinical-stage biotechnology company focused on developing targeted RNA therapeutics for rare genetic neuromuscular disorders. Its lead program, ATX-01, is currently in c...

Read more

El CDTI Innovación invierte, junto con NARA Health Capital, en Gyala Therapeutics SL, biotech que desarrolla una nueva inmunoterapia basada en la tecnología CAR-T

by CDTI Innovación

La ronda de financiación en la que participan CDTI Innovación y NARA Health Capital, junto con Invivo Ventures, permitirá a Gyala llevar a cabo un ensayo clínico de Fase I en pacientes con leucemi...

Read more

Pulmobiotics, backed by Invivo Ventures, receives 1.9m euros to develop ‘living medicine’ for lung cancer

by Invivo Capital

Researchers at Pulmobiotics, a start-up founded in 2020 at the Centre for Genomic Regulation (CRG) in Barcelona backed by Invivo Ventures, have begun work on a ‘living medicine’ to improve the eff...

Read more

El CDTI invierte junto a Invivo Ventures en Telomere Therapeutics, startup biotecnológica que pretende desarrollar nuevos tratamientos para enfermedades asociadas a síndromes teloméricos

by CDTI Innovación

El CDTI, a través de su programa Innvierte, conjuntamente con Invivo Ventures, han alcanzado un acuerdo con los socios de Telomere Therapeutics, S.L. para entrar en el capital de la startup. La aport...

Read more

Telum Therapeutics raises € 4.1 million in its first round, led by Invivo Ventures, together with the co-investment of Clave Capital and CDTI-Innvierte

by Invivo Capital

Telum Therapeutics (‘Telum’), an emerging biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages, called enzybiotics, has ...

Read more

El CDTI invierte junto a Invivo Ventures en Arthex Biotech, startup biotecnológica que pretende desarrollar nuevos tratamientos para la distrofia miotónica

by CDTI Innovación

El CDTI, a través de su programa Innvierte, conjuntamente con Invivo Ventures, han alcanzado un acuerdo con los socios de Arthex Biotech, S.L. para entrar en el capital de la startup. La aportación ...

Read more

A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS (Barcelona) secures a 1.5 million-euro investment from Invivo Ventures

by Invivo Capital

Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating hematological malignancies. The company raised

Read more

Lluís Pareras, from Invivo Ventures: 'Stopping now would be a mistake'

by Invivo Capital

Stopping now would be a mistake, because science and biotechnology will play a huge role in society and, for those who don’t stop now, having the advantage of these 2 quarters will be key. It is tim...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream